Homozygous Hereditary C3 Deficiency Due to a Partial Gene Deletion

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1992 Jun 1

PMID 1350678

Citations 15

Authors

M Botto

K Y Fong

A K So

R Barlow

R ROUTIER

B J Morley

M J Walport

Affiliations

Soon will be listed here.

Abstract

The molecular mechanism of C3 deficiency in an Afrikaans patient with recurrent pyogenic infections was studied. Restriction enzyme analysis showed a gene deletion of 800 base pairs (bp) mapping to the alpha chain of C3. Amplification of genomic DNA, using the PCR, demonstrated that the deletion included exons 22 and 23 of the C3 gene. Truncated mRNA was shown in an Epstein-Barr virus-transformed B-cell line by PCR amplification of first-strand cDNA. A consequence of this deletion was that the RNA transcribed 3' to the deletion was out of frame, resulting in formation of a stop codon 19 bp downstream from the deletion. The molecular basis of the deletion was compatible with homologous recombination between two Alu sequences located in introns 21 and 23. An unrelated nonconsanguineous relative and two of a sample of 174 Afrikaans-speaking individuals were heterozygous carriers of the same gene deletion. The wide prevalence of this null allele in this population is probably due to the effects of a small founder population. The presence of this deletion in the C3 gene is not compatible with production of any functional C3, supporting the idea that study of such patients offers a valid model for understanding physiological activities of C3 in vivo in humans.

Citing Articles

The yin and the yang of early classical pathway complement disorders.

Sullivan K Clin Exp Immunol. 2022; 209(2):151-160.

PMID: 35648651 PMC: 9390844. DOI: 10.1093/cei/uxac056.

The cell biology of synapse formation.

Sudhof T J Cell Biol. 2021; 220(7).

PMID: 34086051 PMC: 8186004. DOI: 10.1083/jcb.202103052.

Targeting complement components C3 and C5 for the retina: Key concepts and lingering questions.

Kim B, Mastellos D, Li Y, Dunaief J, Lambris J Prog Retin Eye Res. 2020; 83:100936.

PMID: 33321207 PMC: 8197769. DOI: 10.1016/j.preteyeres.2020.100936.

Human inborn errors of immunity to infection affecting cells other than leukocytes: from the immune system to the whole organism.

Zhang S, Jouanguy E, Zhang Q, Abel L, Puel A, Casanova J Curr Opin Immunol. 2019; 59:88-100.

PMID: 31121434 PMC: 6774828. DOI: 10.1016/j.coi.2019.03.008.

Expanding Complement Therapeutics for the Treatment of Paroxysmal Nocturnal Hemoglobinuria.

Mastellos D, Reis E, Yancopoulou D, Risitano A, Lambris J Semin Hematol. 2018; 55(3):167-175.

PMID: 30032754 PMC: 6060635. DOI: 10.1053/j.seminhematol.2018.02.002.

References

Roord J, Daha M, Kuis W, Verbrugh H, Verhoef J, Zegers B . Inherited deficiency of the third component of complement associated with recurrent pyogenic infections, circulating immune complexes, and vasculitis in a Dutch family. Pediatrics. 1983; 71(1):81-7. View

Paolella G, Lucero M, Murphy M, Baralle F . The Alu family repeat promoter has a tRNA-like bipartite structure. EMBO J. 1983; 2(5):691-6. PMC: 555171. DOI: 10.1002/j.1460-2075.1983.tb01486.x. View

Davis 3rd A, Davis 4th J, Rabson A, Osofsky S, Colten H, Rosen F . Homozygous C3 deficiency: detection of C3 by radioimmunoassay. Clin Immunol Immunopathol. 1977; 8(3):543-50. DOI: 10.1016/0090-1229(77)90019-8. View

Alper C, Colten H, Gear J, Rabson A, Rosen F . Homozygous human C3 deficiency. The role of C3 in antibody production, C-1s-induced vasopermeability, and cobra venom-induced passive hemolysis. J Clin Invest. 1976; 57(1):222-9. PMC: 436642. DOI: 10.1172/JCI108263. View

Grace H, Vos G, Schonland M . A family with partial and total deficiency of complement C3. S Afr Med J. 1976; 50(5):139-40. View

Neote K, McInnes B, Mahuran D, Gravel R . Structure and distribution of an Alu-type deletion mutation in Sandhoff disease. J Clin Invest. 1990; 86(5):1524-31. PMC: 296899. DOI: 10.1172/JCI114871. View

Botto M, Fong K, So A, Rudge A, Walport M . Molecular basis of hereditary C3 deficiency. J Clin Invest. 1990; 86(4):1158-63. PMC: 296845. DOI: 10.1172/JCI114821. View

Krug M, Berger S . First-strand cDNA synthesis primed with oligo(dT). Methods Enzymol. 1987; 152:316-25. DOI: 10.1016/0076-6879(87)52036-5. View

Miura O, Sugahara Y, Nakamura Y, Hirosawa S, Aoki N . Restriction fragment length polymorphism caused by a deletion involving Alu sequences within the human alpha 2-plasmin inhibitor gene. Biochemistry. 1989; 28(12):4934-8. DOI: 10.1021/bi00438a003. View

10.

Huang L, Ripps M, Korman S, Deckelbaum R, Breslow J . Hypobetalipoproteinemia due to an apolipoprotein B gene exon 21 deletion derived by Alu-Alu recombination. J Biol Chem. 1989; 264(19):11394-400. View

11.

Weiss R, SCHULZ E . Complement deficiency in Sweet's syndrome. Br J Dermatol. 1989; 121(3):413-5. DOI: 10.1111/j.1365-2133.1989.tb01441.x. View

12.

Borzy M, Gewurz A, Wolff L, Houghton D, LOVRIEN E . Inherited C3 deficiency with recurrent infections and glomerulonephritis. Am J Dis Child. 1988; 142(1):79-83. DOI: 10.1001/archpedi.1988.02150010089032. View

13.

Britten R, Baron W, Stout D, Davidson E . Sources and evolution of human Alu repeated sequences. Proc Natl Acad Sci U S A. 1988; 85(13):4770-4. PMC: 280517. DOI: 10.1073/pnas.85.13.4770. View

14.

Alper C, Colten H, Rosen F, Rabson A, MACNAB G, Gear J . Homozygous deficiency of C3 in a patient with repeated infections. Lancet. 1972; 2(7788):1179-81. DOI: 10.1016/s0140-6736(72)92598-6. View

15.

Jagadeeswaran P, Tuan D, Forget B, Weissman S . A gene deletion ending at the midpoint of a repetitive DNA sequence in one form of hereditary persistence of fetal haemoglobin. Nature. 1982; 296(5856):469-70. DOI: 10.1038/296469a0. View

16.

Ottolenghi S, Giglioni B . The deletion in a type of delta 0-beta 0-thalassaemia begins in an inverted AluI repeat. Nature. 1982; 300(5894):770-1. DOI: 10.1038/300770a0. View

17.

Feinberg A, Vogelstein B . A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983; 132(1):6-13. DOI: 10.1016/0003-2697(83)90418-9. View

18.

Kitamura H, Nishimukai H, Sano Y, Nagaki K . Study on C3-like factor in the serum of a C3-deficient subject. Immunology. 1984; 51(2):239-45. PMC: 1454427. View

19.

SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

20.

Osofsky S, Thompson B, Lint T, Gewurz H . Hereditary deficiency of the third component of complement in a child with fever, skin rash, and arthralgias: response to transfusion of whole blood. J Pediatr. 1977; 90(2):180-6. DOI: 10.1016/s0022-3476(77)80626-4. View